Adrenal hypoplasia congenita (AHC) is caused by mutations in the NR0B1 gene on chromosome Xp21.3-p21.2. It manifests as X-linked primary adrenal failure in early infancy or childhood and as hypogonadotropic hypogonadism (HHG) at puberty. Although studies of AHC patients and mutations in the NR0B1 gene have been reported throughout the world, there has previously been only one other case report from Korea. We encountered a 23-year old Korean male with delayedonset AHC/HHG who had been previously diagnosed with adrenal insufficiency of unknown aetiology at age 13 years. Delayed puberty and incomplete HHG were observed. Direct sequencing of the NR0B1 gene revealed the patient to have a novel insertion mutation (c.959_960insT; Leu321ProfsX68). Although AHC is believed to be rare, it should be considered in a differential diagnosis of patients showing late-onset primary adrenal insufficiency.
Introduction
X-linked adrenal hypoplasia congenita (AHC; OMIM 300200) is a rare congenital adrenal disorder that is characterized by primary adrenal insufficiency early in life and by hypogonadotropic hypogonadism (HHG) during adolescence. This disorder often manifests as a salt-losing adrenal Y-W Lee, JC Won, C-S Ki et al. Adrenal hypoplasia congenita with a novel mutation insufficiency during the neonatal period and can be fatal if left untreated. 1 The condition is caused by mutations of the nuclear receptor subfamily 0, group B member 1 (NR0B1), which is also known as the DAX-1 (dosagesensitive sex reversal AHC critical region of the X chromosome, gene 1) gene that controls the development of the adrenal and the hypothalamic-pituitary-gonadal axis.
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Although details of AHC patients and mutations in the NR0B1 gene have been reported worldwide, there has previously been only one other case report from Korea. 4 Considering the many reports of AHC among the Japanese population, the incidence of AHC might be underestimated in Korea because late-onset adrenal insufficiency and incomplete HHG may preclude accurate diagnosis of AHC. 5 This report details an atypical case of delayed-onset AHC with incomplete HHG and a novel insertion mutation (c.959_960insT; Leu321ProfsX68) in the NR0B1 gene.
Case report CLINICAL FINDINGS
A 23-year-old man was referred with suspected adrenocortical failure. He complained of fatigue, nausea, epigastric soreness and dizziness, and had lost up to 5.2 kg in body mass over a period of several weeks. He had experienced several adrenal crises during upper respiratory infections or acute gastroenteritis since he was 13 years old. He was diagnosed with adrenal insufficiency of unknown aetiology from the results of an incomplete response to the adrenocorticotropic hormone (ACTH) stimulation test. Accordingly, the patient was administered 5 -15 mg/day prednisolone. His prior history revealed that the first signs of puberty occurred when he was 17 years of age. His elder sister showed an unremarkable past and current medical history.
The patient's height and weight were 194 cm and 58 kg, respectively, and systolic and diastolic blood pressures were 100 and 60 mmHg, respectively. Physical examination revealed only scant pubic hair (Tanner stage 3). He had no gynaecomastia but testicular volume was low (4 ml bilaterally). A few hyperpigmented macules were noted on the lips and oral mucosa. A computerized tomography scan of the abdomen revealed small non-calcified adrenal glands with no evidence of tuberculosis. Magnetic resonance imaging of the pituitary gland did not show any definite abnormality.
Diagnosis of a primary adrenal insufficiency was confirmed by an elevated 08.00 h serum ACTH (146.3 pg/ml; reference range, 10 -60 pg/ml) along with a low cortisol concentration (1.44 µg/dl; reference range, 2 -25 µg/dl) and lack of response to cosyntropin stimulation. Serum sodium and potassium concentrations were 131 and 5.6 mmol/l, respectively, and serum osmolality was decreased (261 mOsm/kg; reference range, 270 -310 mOsm/kg). The serum aldosterone level was undetectable, whereas the plasma renin activity was increased (1.39 ng/ml per h; reference range, 0.68 -1.36 ng/ml per h) in the supine position. Serum concentrations of dehydroepiandrosterone sulphate and 17-hydroxyprogesterone were low (10 pg/ml; reference range, 80 -560 pg/ml and 0.42 ng/ml; reference range, 0.60 -3.42 ng/ml, respectively).
The anti-adrenocortical antibody test was negative, and levels of very-long chain fatty acids were within the reference range. Serum testosterone concentrations ranged from 0.77 to 1.51 ng/ml (reference range, 2.45 -18.36 ng/ml). Basal serum follicle stimulating hormone and luteinizing hormone concentrations were within the normal range but increased Y-W Lee, JC Won, C-S Ki et al. Adrenal hypoplasia congenita with a novel mutation to 7.08 and 10.25 mIU/ml, respectively, after an injection of 0.1 mg gonadorelin. Serum levels of prolactin, growth hormone and thyroid hormone were normal. Semen analysis revealed azoospermia.
Steroid supplementation with hydrocortisone and fluorocortisone resulted in rapid improvement in his clinical condition, which was maintained with 15 -35 mg/day hydrocortisone.
MOLECULAR GENETIC ANALYSIS
After obtaining informed consent, blood samples were collected from the proband and his mother. Genomic DNA was isolated from peripheral blood leucocytes using a Wizard Genomic DNA Purification kit according to the manufacturer's instructions (Promega, Madison, WI, USA). All the coding exons as well as the flanking introns of the NR0B1 gene were amplified by polymerase chain reaction using primer sets designed by the authors (available from the authors on request). Direct sequencing was carried out using a BigDye ® Terminator Cycle Sequencing Ready Reaction Kit (Applied Biosystems, Foster City, CA, USA) and an ABI Prism ® 3100 Genetic Analyzer (Applied Biosystems, Foster City, CA, USA). All the novel mutations were confirmed by sequencing 100 control chromosomes. Direct sequencing analysis of all the coding exons and their flanking intronic sequences demonstrated that the patient had a novel insertion mutation in exon 1 of the NR0B1 gene (c.959_960insT; Leu321ProfsX68). Further analysis of his family members showed that the patient's mother was a heterozygous carrier of this mutation (Fig. 1) .
Discussion
An unusual case of X-linked AHC that presented as late-onset adrenal insufficiency FIGURE 1: Mutation analysis of the NR0B1 gene from a patient with X-linked adrenal hypoplasia congenita and his mother. Direct sequencing of exon 1 shows an additional peak (open arrow) from nucleotide position 960 due to a one base pair insertion (c.959_960insT; Leu321ProfsX68) in the proband and overlapping peaks due to a heterozygous one base pair insertion in his mother (black arrow).
Reference mRNA sequence
Reference amino acid sequence Mother Proband Adrenal hypoplasia congenita with a novel mutation and incomplete HHG with a novel mutation in exon 1 of the NR0B1 gene (c.959_960insT; Leu321ProfsX68) is discussed.
X-linked AHC is characterized by infantile-onset acute adrenal insufficiency at an average age of 3 weeks in approximately 60% of affected individuals. Onset occurs in childhood in approximately 40% of cases. A few individuals present in adulthood with infertility. Adrenal insufficiency typically presents acutely as vomiting, feeding difficulty, dehydration and shock caused by a salt-wasting episode. Hypoglycaemia, frequently presenting with seizures, might be the first symptom of X-linked AHC. If left untreated, the adrenal insufficiency is rapidly lethal due to hyperkalaemia, acidosis, hypoglycaemia, and shock. Cryptorchidism may be observed. Affected males typically show delayed puberty (onset after 14 years of age) caused by HHG.
Although AHC tends to occur early in life, physicians who are unfamiliar with its wide spectrum of phenotypic manifestations may not consider it in differential diagnosis, which can delay accurate diagnosis. 6 In the patient reported here, the delayed onset of adrenal insufficiency and partial HHG contrasted markedly with classical AHC. Although the pituitary-gonadal axis might be intact in early infancy with AHC, failure to undergo puberty due to HHG is a hallmark of this disorder. 11 -13 In the patient reported here, delayed onset of puberty was observed although secondary sexual characteristics did not appear.
In conclusion, this paper reports a Korean patient with X-linked AHC who was diagnosed through molecular genetic analysis of the NR0B1 gene. This case extends the phenotypic spectrum of X-linked AHC to include delayed onset of adrenocortical insufficiency and incomplete HHG. AHC should be considered when making a differential diagnosis of patients exhibiting an unexplained late-onset adrenal insufficiency with incomplete HHG, and NR0B1 gene analysis should be performed.
